Kelix Bio Acquires Chemi Pharma’s Injectable Oncology Facility
Deal Struck For Maltese Plant As Company Targets Emerging Markets
Kelix Bio has acquired Chemi Pharma’s injectables manufacturing facility in Malta as part of its efforts to improve access to generic oncology therapies across global emerging markets. Kelix has manufacturing operations in India, Egypt and Malta and markets its products in over 40 countries across Africa, Asia and Latin America.
